The Company’s presentations are listed below. Following congress publication, copies of the presentations will be available in the "Publications & Presentations" section of the Company's website at ...

Sickle cell disease doesn’t discriminate, but it does disproportionately affect those with the least access to healthcare ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at the Medical University of South Carolina ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC joined forces to create and test an ...

New studies show that astrocytes, long thought to be support cells in the brain, are crucial intermediaries for relaying messages to neurons.

However, toxicological information on their effects on red blood cells (RBCs) and the mechanisms involved remain sparse. In this article, we examined the size dependent nanotoxicity of AgNPs using ...

The body’s pathogen fighters can act as surveillance forces that ferry information from the gut and fat deposits to the brain ...

Miniature organs on a chip could allow us to do scientific studies with great precision, without having to resort to animal testing. The main problem, however, is that artificial tissue needs blood ...

Pneumococcal meningitis was associated with a case-fatality rate of almost 30% in children with sickle cell disease, a study ...

Cell and gene therapy (C&GT) is set to revolutionise treatment of complex diseases, offering new possibilities for patients.

Researchers in India have created the ICMR-SCD Stigma Scale (ISSSI) to assess stigma in sickle cell disease patients and ...